Filter
2454
Filtered Results: 2454
Text search:
TB
burden
Featured
Recommendations
209
New Publications
699
Language
Document type
No document type
1608
Studies & Reports
366
Guidelines
224
Strategic & Response Plan
87
Manuals
63
Situation Updates
42
Fact sheets
36
Training Material
19
Infographics
4
Resource Platforms
3
Brochures
2
Countries / Regions
India
122
Kenya
98
South Africa
95
Western and Central Europe
83
Global
75
Uganda
59
Tanzania
57
Nigeria
53
Ethiopia
52
Malawi
49
Zambia
49
Africa
45
Eastern Europe
44
Namibia
44
Nepal
43
Sierra Leone
42
Liberia
39
Ghana
37
Myanmar / Burma
37
Bangladesh
35
Rwanda
34
Ukraine
32
Lesotho
30
Asia
27
Latin America and the Carribbean
27
South–East Asia Region
25
Cambodia
24
Zimbabwe
22
Philippines
18
Mozambique
15
Russia
15
Botswana
15
Indonesia
15
Germany
11
Congo, Democratic Republic of
10
Eswatini/ Swaziland
10
Pakistan
10
Senegal
9
East and Southern Africa
9
South Sudan
9
Syria
8
Colombia
7
Haiti
7
Brazil
7
Venezuela
5
West and Central Africa
5
Sudan
5
Georgia
5
Tajikistan
4
Timor Leste/ East Timor
4
Thailand
4
Iran
4
Albania
4
Afghanistan
4
Peru
4
Guinea
4
Armenia
4
Jordan
4
Middle East and North Africa
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Paraguay
4
Southern Africa
4
Argentina
4
Vietnam
4
Laos
3
Burkina Faso
3
USA
3
North America
3
Lebanon
3
Papua New Guinea
3
Sri Lanka
3
Somalia
3
Ecuador
3
North Macedonia
2
Benin
2
Cameroon
2
Burundi
2
Saudi Arabia
2
Moldova
2
Yemen
2
Romania
2
Central African Republic
2
Angola
2
Bhutan
2
Iraq
2
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Estonia
1
Morocco
1
Qatar
1
Bulgaria
1
Ireland
1
Gabon
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
Belarus
1
Israel
1
Bolivia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Poland
1
Libya
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1093
Clinical Guidelines
172
Public Health
103
Women & Child Health
49
Key Resources
47
Capacity Building
20
Pharmacy & Technologies
18
Annual Report MEDBOX
2
Toolboxes
TB
573
HIV
356
AMR
99
COVID-19
83
Mental Health
57
NTDs
45
Caregiver
43
Global Health Education
42
Refugee
35
NCDs
35
Health Financing Toolbox
32
Pharmacy
25
Conflict
23
Planetary Health
22
Disability
21
Polio
19
Rapid Response
16
Ebola & Marburg
16
Natural Hazards
13
Social Ethics
5
Cholera
3
Specific Hazards
2
Zika
2
South Sudan
1
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
30 October 2017
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Estimates of TB burden
Public Health Action PHA 2017; 7(2): 110–115
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
On the road to ending TB
Highlights from the 30 highest TB burden countries
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate the recent increase in TB incidence in the region, we selected 12 countries from Latin America (Argentina,
Brazil, Chile, Colombia, Ecuador, El Salvador...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Because of the limited access to more powerful diagnostic tools, there is a paucity of data regarding the burden of fungal infections in Burkina Faso. The aim of this study was to estimate the incidence and prevalence of serious fungal infections in this sub-Saharan country. We primarily used the na...
Therapy for MDR-TB is extremely long, complex and burdensome to both patients and health care systems. A single diagnosis can require two years of treatment, or longer. When treating children, there are significant additional barriers treating children with MDR-TB. There is limited data on the pharm...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)...
Globally, it is estimated that 1 billion people suffer from acute and chronic respiratory conditions, making them major causes of illness and death. Although there is a relative lack of data and evidence on lung diseases beyond tuberculosis (TB) in Sub-Saharan Africa (SSA), their estimated regional ...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
This strategic framework marries formerly separate mandates for HIV and TB management in to one, comprehensive collaboration. It provides a structure for how to: strengthen the health care system to respond effectively to both epidemics, reduce the burden of HIV/AIDS in TB patients, and establish a ...
